BFEC
RDY icon

Benjamin F. Edwards & Company’s Dr. Reddy's Laboratories RDY Stock Holding History

Benjamin F. Edwards & Company’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$5K Sell
335
-15
-4% -$215 ﹤0.01% 1892
2024
Q1 		$5K Hold
350
– – ﹤0.01% 1880
2023
Q4 		$5K Buy
+350
New +$4.68K ﹤0.01% 1864

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Benjamin F. Edwards & Company's RDY Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Dr. Reddy's Laboratories (RDY) stake by 4.3% in Q2 2024, selling an estimated $215 and leaving 335 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

Benjamin F. Edwards & Company first reported a position in RDY in Q4 2023 and has held it in 3 quarters since. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Benjamin F. Edwards & Company held 335 shares of Dr. Reddy's Laboratories worth $5K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 15 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $215.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1892 holding.
  • Benjamin F. Edwards & Company first reported a position in Dr. Reddy's Laboratories in Q4 2023 and has held it in 3 quarters since.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.